Cargando…
The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas
Despite the fact that the majority of lymphomas initially respond to treatment, many patients relapse and die from disease that is refractory to current regimens. The need for new treatment strategies in lymphomas has led to the investigation and evaluation of novel agents that target cellular pathw...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124126/ https://www.ncbi.nlm.nih.gov/pubmed/21822434 http://dx.doi.org/10.1155/2012/435342 |